Dental Engine
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
1 TB Disease Vaccine Market Overview 1.1 Product Overview and Scope of TB Disease Vaccine 1.2 TB Disease Vaccine Segment by Type 1.2.1 Global TB Disease Vaccine Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Prevention Vaccines 1.2.3 Post-exposure Vaccines 1.2.4 Others 1.3 TB Disease Vaccine Segment by Application 1.3.1 Global TB Disease Vaccine Sales Comparison by Application: (2022-2028) 1.3.2 Self-Procurement 1.3.3 UNICEF 1.3.4 Others 1.4 Global TB Disease Vaccine Market Size Estimates and Forecasts 1.4.1 Global TB Disease Vaccine Revenue 2017-2028 1.4.2 Global TB Disease Vaccine Sales 2017-2028 1.4.3 TB Disease Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028 2 TB Disease Vaccine Market Competition by Manufacturers 2.1 Global TB Disease Vaccine Sales Market Share by Manufacturers (2017-2022) 2.2 Global TB Disease Vaccine Revenue Market Share by Manufacturers (2017-2022) 2.3 Global TB Disease Vaccine Average Price by Manufacturers (2017-2022) 2.4 Manufacturers TB Disease Vaccine Manufacturing Sites, Area Served, Product Type 2.5 TB Disease Vaccine Market Competitive Situation and Trends 2.5.1 TB Disease Vaccine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest TB Disease Vaccine Players Market Share by Revenue 2.5.3 Global TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 TB Disease Vaccine Retrospective Market Scenario by Region 3.1 Global TB Disease Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global TB Disease Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America TB Disease Vaccine Market Facts & Figures by Country 3.3.1 North America TB Disease Vaccine Sales by Country 3.3.2 North America TB Disease Vaccine Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe TB Disease Vaccine Market Facts & Figures by Country 3.4.1 Europe TB Disease Vaccine Sales by Country 3.4.2 Europe TB Disease Vaccine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific TB Disease Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific TB Disease Vaccine Sales by Region 3.5.2 Asia Pacific TB Disease Vaccine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America TB Disease Vaccine Market Facts & Figures by Country 3.6.1 Latin America TB Disease Vaccine Sales by Country 3.6.2 Latin America TB Disease Vaccine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.6.6 Colombia 3.7 Middle East and Africa TB Disease Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa TB Disease Vaccine Sales by Country 3.7.2 Middle East and Africa TB Disease Vaccine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global TB Disease Vaccine Historic Market Analysis by Type 4.1 Global TB Disease Vaccine Sales Market Share by Type (2017-2022) 4.2 Global TB Disease Vaccine Revenue Market Share by Type (2017-2022) 4.3 Global TB Disease Vaccine Price by Type (2017-2022) 5 Global TB Disease Vaccine Historic Market Analysis by Application 5.1 Global TB Disease Vaccine Sales Market Share by Application (2017-2022) 5.2 Global TB Disease Vaccine Revenue Market Share by Application (2017-2022) 5.3 Global TB Disease Vaccine Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Merck 6.1.1 Merck Corporation Information 6.1.2 Merck Description and Business Overview 6.1.3 Merck TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Merck TB Disease Vaccine Product Portfolio 6.1.5 Merck Recent Developments/Updates 6.2 Japan BCG Lab 6.2.1 Japan BCG Lab Corporation Information 6.2.2 Japan BCG Lab Description and Business Overview 6.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Japan BCG Lab TB Disease Vaccine Product Portfolio 6.2.5 Japan BCG Lab Recent Developments/Updates 6.3 Serum Institute of India 6.3.1 Serum Institute of India Corporation Information 6.3.2 Serum Institute of India Description and Business Overview 6.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Serum Institute of India TB Disease Vaccine Product Portfolio 6.3.5 Serum Institute of India Recent Developments/Updates 6.4 AJ Vaccines 6.4.1 AJ Vaccines Corporation Information 6.4.2 AJ Vaccines Description and Business Overview 6.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.4.4 AJ Vaccines TB Disease Vaccine Product Portfolio 6.4.5 AJ Vaccines Recent Developments/Updates 6.5 BioFarma 6.5.1 BioFarma Corporation Information 6.5.2 BioFarma Description and Business Overview 6.5.3 BioFarma TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.5.4 BioFarma TB Disease Vaccine Product Portfolio 6.5.5 BioFarma Recent Developments/Updates 6.6 GreenSignal Bio Pharma 6.6.1 GreenSignal Bio Pharma Corporation Information 6.6.2 GreenSignal Bio Pharma Description and Business Overview 6.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.6.4 GreenSignal Bio Pharma TB Disease Vaccine Product Portfolio 6.6.5 GreenSignal Bio Pharma Recent Developments/Updates 6.7 China National Biotec 6.6.1 China National Biotec Corporation Information 6.6.2 China National Biotec Description and Business Overview 6.6.3 China National Biotec TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.4.4 China National Biotec TB Disease Vaccine Product Portfolio 6.7.5 China National Biotec Recent Developments/Updates 6.8 Biomed Lublin 6.8.1 Biomed Lublin Corporation Information 6.8.2 Biomed Lublin Description and Business Overview 6.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Biomed Lublin TB Disease Vaccine Product Portfolio 6.8.5 Biomed Lublin Recent Developments/Updates 6.9 Taj Pharmaceuticals 6.9.1 Taj Pharmaceuticals Corporation Information 6.9.2 Taj Pharmaceuticals Description and Business Overview 6.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Taj Pharmaceuticals TB Disease Vaccine Product Portfolio 6.9.5 Taj Pharmaceuticals Recent Developments/Updates 6.10 Ataulpho de Paiva 6.10.1 Ataulpho de Paiva Corporation Information 6.10.2 Ataulpho de Paiva Description and Business Overview 6.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Ataulpho de Paiva TB Disease Vaccine Product Portfolio 6.10.5 Ataulpho de Paiva Recent Developments/Updates 6.11 IVAC 6.11.1 IVAC Corporation Information 6.11.2 IVAC TB Disease Vaccine Description and Business Overview 6.11.3 IVAC TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.11.4 IVAC TB Disease Vaccine Product Portfolio 6.11.5 IVAC Recent Developments/Updates 6.12 Queen Saovabha Mem. Inst 6.12.1 Queen Saovabha Mem. Inst Corporation Information 6.12.2 Queen Saovabha Mem. Inst TB Disease Vaccine Description and Business Overview 6.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Queen Saovabha Mem. Inst TB Disease Vaccine Product Portfolio 6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates 6.13 Microgen 6.13.1 Microgen Corporation Information 6.13.2 Microgen TB Disease Vaccine Description and Business Overview 6.13.3 Microgen TB Disease Vaccine Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Microgen TB Disease Vaccine Product Portfolio 6.13.5 Microgen Recent Developments/Updates 7 TB Disease Vaccine Manufacturing Cost Analysis 7.1 TB Disease Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of TB Disease Vaccine 7.4 TB Disease Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 TB Disease Vaccine Distributors List 8.3 TB Disease Vaccine Customers 9 TB Disease Vaccine Market Dynamics 9.1 TB Disease Vaccine Industry Trends 9.2 TB Disease Vaccine Market Drivers 9.3 TB Disease Vaccine Market Challenges 9.4 TB Disease Vaccine Market Restraints 10 Global Market Forecast 10.1 TB Disease Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of TB Disease Vaccine by Type (2023-2028) 10.1.2 Global Forecasted Revenue of TB Disease Vaccine by Type (2023-2028) 10.2 TB Disease Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of TB Disease Vaccine by Application (2023-2028) 10.2.2 Global Forecasted Revenue of TB Disease Vaccine by Application (2023-2028) 10.3 TB Disease Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of TB Disease Vaccine by Region (2023-2028) 10.3.2 Global Forecasted Revenue of TB Disease Vaccine by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global TB Disease Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global TB Disease Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global TB Disease Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global TB Disease Vaccine Market Competitive Situation by Manufacturers in 2021 Table 5. Global TB Disease Vaccine Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global TB Disease Vaccine Sales Market Share by Manufacturers (2017-2022) Table 7. Global TB Disease Vaccine Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global TB Disease Vaccine Revenue Share by Manufacturers (2017-2022) Table 9. Global Market TB Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers TB Disease Vaccine Manufacturing Sites and Area Served Table 11. Manufacturers TB Disease Vaccine Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global TB Disease Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TB Disease Vaccine as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global TB Disease Vaccine Sales by Region (2017-2022) & (K Units) Table 16. Global TB Disease Vaccine Sales Market Share by Region (2017-2022) Table 17. Global TB Disease Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 18. Global TB Disease Vaccine Revenue Market Share by Region (2017-2022) Table 19. North America TB Disease Vaccine Sales by Country (2017-2022) & (K Units) Table 20. North America TB Disease Vaccine Sales Market Share by Country (2017-2022) Table 21. North America TB Disease Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 22. North America TB Disease Vaccine Revenue Market Share by Country (2017-2022) Table 23. Europe TB Disease Vaccine Sales by Country (2017-2022) & (K Units) Table 24. Europe TB Disease Vaccine Sales Market Share by Country (2017-2022) Table 25. Europe TB Disease Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe TB Disease Vaccine Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific TB Disease Vaccine Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific TB Disease Vaccine Sales Market Share by Region (2017-2022) Table 29. Asia Pacific TB Disease Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific TB Disease Vaccine Revenue Market Share by Region (2017-2022) Table 31. Latin America TB Disease Vaccine Sales by Country (2017-2022) & (K Units) Table 32. Latin America TB Disease Vaccine Sales Market Share by Country (2017-2022) Table 33. Latin America TB Disease Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America TB Disease Vaccine Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa TB Disease Vaccine Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa TB Disease Vaccine Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa TB Disease Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa TB Disease Vaccine Revenue Market Share by Country (2017-2022) Table 39. Global TB Disease Vaccine Sales by Type (2017-2022) & (K Units) Table 40. Global TB Disease Vaccine Sales Market Share by Type (2017-2022) Table 41. Global TB Disease Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 42. Global TB Disease Vaccine Revenue Share by Type (2017-2022) Table 43. Global TB Disease Vaccine Price by Type (2017-2022) & (US$/Unit) Table 44. Global TB Disease Vaccine Sales (K Units) by Application (2017-2022) Table 45. Global TB Disease Vaccine Sales Market Share by Application (2017-2022) Table 46. Global TB Disease Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 47. Global TB Disease Vaccine Revenue Share by Application (2017-2022) Table 48. Global TB Disease Vaccine Price by Application (2017-2022) & (US$/Unit) Table 49. Merck Corporation Information Table 50. Merck Description and Business Overview Table 51. Merck TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Merck TB Disease Vaccine Product Table 53. Merck Recent Developments/Updates Table 54. Japan BCG Lab Corporation Information Table 55. Japan BCG Lab Description and Business Overview Table 56. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Japan BCG Lab TB Disease Vaccine Product Table 58. Japan BCG Lab Recent Developments/Updates Table 59. Serum Institute of India Corporation Information Table 60. Serum Institute of India Description and Business Overview Table 61. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Serum Institute of India TB Disease Vaccine Product Table 63. Serum Institute of India Recent Developments/Updates Table 64. AJ Vaccines Corporation Information Table 65. AJ Vaccines Description and Business Overview Table 66. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. AJ Vaccines TB Disease Vaccine Product Table 68. AJ Vaccines Recent Developments/Updates Table 69. BioFarma Corporation Information Table 70. BioFarma Description and Business Overview Table 71. BioFarma TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. BioFarma TB Disease Vaccine Product Table 73. BioFarma Recent Developments/Updates Table 74. GreenSignal Bio Pharma Corporation Information Table 75. GreenSignal Bio Pharma Description and Business Overview Table 76. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. GreenSignal Bio Pharma TB Disease Vaccine Product Table 78. GreenSignal Bio Pharma Recent Developments/Updates Table 79. China National Biotec Corporation Information Table 80. China National Biotec Description and Business Overview Table 81. China National Biotec TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. China National Biotec TB Disease Vaccine Product Table 83. China National Biotec Recent Developments/Updates Table 84. Biomed Lublin Corporation Information Table 85. Biomed Lublin Description and Business Overview Table 86. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. Biomed Lublin TB Disease Vaccine Product Table 88. Biomed Lublin Recent Developments/Updates Table 89. Taj Pharmaceuticals Corporation Information Table 90. Taj Pharmaceuticals Description and Business Overview Table 91. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. Taj Pharmaceuticals TB Disease Vaccine Product Table 93. Taj Pharmaceuticals Recent Developments/Updates Table 94. Ataulpho de Paiva Corporation Information Table 95. Ataulpho de Paiva Description and Business Overview Table 96. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Ataulpho de Paiva TB Disease Vaccine Product Table 98. Ataulpho de Paiva Recent Developments/Updates Table 99. IVAC Corporation Information Table 100. IVAC Description and Business Overview Table 101. IVAC TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. IVAC TB Disease Vaccine Product Table 103. IVAC Recent Developments/Updates Table 104. Queen Saovabha Mem. Inst Corporation Information Table 105. Queen Saovabha Mem. Inst Description and Business Overview Table 106. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 107. Queen Saovabha Mem. Inst TB Disease Vaccine Product Table 108. Queen Saovabha Mem. Inst Recent Developments/Updates Table 109. Microgen Corporation Information Table 110. Microgen Description and Business Overview Table 111. Microgen TB Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 112. Microgen TB Disease Vaccine Product Table 113. Microgen Recent Developments/Updates Table 114. Production Base and Market Concentration Rate of Raw Material Table 115. Key Suppliers of Raw Materials Table 116. TB Disease Vaccine Distributors List Table 117. TB Disease Vaccine Customers List Table 118. TB Disease Vaccine Market Trends Table 119. TB Disease Vaccine Market Drivers Table 120. TB Disease Vaccine Market Challenges Table 121. TB Disease Vaccine Market Restraints Table 122. Global TB Disease Vaccine Sales Forecast by Type (2023-2028) & (K Units) Table 123. Global TB Disease Vaccine Sales Market Share Forecast by Type (2023-2028) Table 124. Global TB Disease Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million) Table 125. Global TB Disease Vaccine Revenue Market Share Forecast by Type (2023-2028) Table 126. Global TB Disease Vaccine Sales Forecast by Application (2023-2028) & (K Units) Table 127. Global TB Disease Vaccine Sales Market Share Forecast by Application (2023-2028) Table 128. Global TB Disease Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million) Table 129. Global TB Disease Vaccine Revenue Market Share Forecast by Application (2023-2028) Table 130. Global TB Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 131. Global TB Disease Vaccine Sales Market Share Forecast by Region (2023-2028) Table 132. Global TB Disease Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million) Table 133. Global TB Disease Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of TB Disease Vaccine Figure 2. Global TB Disease Vaccine Market Share by Type in 2021 & 2028 Figure 3. Prevention Vaccines Product Picture Figure 4. Post-exposure Vaccines Product Picture Figure 5. Others Product Picture Figure 6. Global TB Disease Vaccine Market Share by Application in 2021 & 2028 Figure 7. Self-Procurement Figure 8. UNICEF Figure 9. Others Figure 10. Global TB Disease Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global TB Disease Vaccine Market Size (2017-2028) & (US$ Million) Figure 12. Global TB Disease Vaccine Sales (2017-2028) & (K Units) Figure 13. TB Disease Vaccine Sales Share by Manufacturers in 2021 Figure 14. Global TB Disease Vaccine Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest TB Disease Vaccine Players: Market Share by Revenue in 2021 Figure 16. TB Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global TB Disease Vaccine Sales Market Share by Region (2017-2022) Figure 18. Global TB Disease Vaccine Sales Market Share by Region in 2021 Figure 19. Global TB Disease Vaccine Revenue Market Share by Region (2017-2022) Figure 20. Global TB Disease Vaccine Revenue Market Share by Region in 2021 Figure 21. United States TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. China Taiwan TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Mexico TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Brazil TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Argentina TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Colombia TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Turkey TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Saudi Arabia TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. UAE TB Disease Vaccine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Sales Market Share of TB Disease Vaccine by Type (2017-2022) Figure 45. Manufacturing Cost Structure of TB Disease Vaccine Figure 46. Manufacturing Process Analysis of TB Disease Vaccine Figure 47. TB Disease Vaccine Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed
Merck Japan BCG Lab Serum Institute of India AJ Vaccines BioFarma GreenSignal Bio Pharma China National Biotec Biomed Lublin Taj Pharmaceuticals Ataulpho de Paiva IVAC Queen Saovabha Mem. Inst Microgen
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More